Thursday 8 November 2018
Imperial College, London
Telephone: +44(0)208 977 7997
Website: http://cardio-dialogues.org/
Explore the latest concepts, techniques and developments in cardio-metabolic science, covering the emerging association between diabetes, heart attacks, renal events and stroke. This meeting will explore the relationship between diabetes and cardiovascular disease, including secondary care management of Type 2 diabetes, new therapies and how to reduce macro and microvascular risk.
The content is aimed at Consultants, Specialist Registrars or equivalent, who are concerned with Type 2 diabetes, renal medicine and cardiology, as well as General Practitioners with an interest in these areas.
The programme includes a mix of keynote presentations to discuss how the data and topics covered can be implemented into everyday practice
Key learning points include:
- The relationship between diabetes and heart attacks and strokes, pathophysiology and epidemiology
- The emerging association between diabetes and heart failure including the burden of disease, epidemiology and pathophysiology
- The role of glycaemic control, lipid lowering and blood pressure control in the prevention of cardiovascular disease among those with diabetes
- The benefits of novel therapies on glycaemic control and cardiovascular outcomes focusing on GLP-1 agonists and SGLT2 inhibitors
- The pathophysiology of renal complications in diabetes and therapies that reduce these complications
- The relationship between severe daytime & nocturnal hypoglycaemic episode, CV events, mortality and the frail patient
- The logistical requirements to improve patient exposure to best diabetes care after a major CV event
- The latest data guiding optimal lipid and hypertension management for patients with CKD, T2DM and treatment following a cardiovascular event.
